Fidelity Investments’s Allergan plc AGN.PRA Stock Holding History

Fidelity Investments’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-197,124	Closed	-$115M	–	2783
2017 Q4	$115M	Sell	197,124 -33,945	-15%	-$21.9M	0.01%	930
2017 Q3	$169M	Buy	231,069 +13,800	+6%	+$11.5M	0.02%	749
2017 Q2	$188M	Sell	217,269 -21,920	-9%	-$18.4M	0.02%	702
2017 Q1	$203M	Sell	239,189 -54,291	-18%	-$45M	0.03%	688
2016 Q4	$224M	Buy	293,480 +35,782	+14%	+$27M	0.03%	622
2016 Q3	$212M	Sell	257,698 -64,480	-20%	-$55.7M	0.03%	644
2016 Q2	$269M	Buy	322,178 +106,315	+49%	+$88.8M	0.04%	536
2016 Q1	$198M	Sell	215,863 -40,381	-16%	-$38.6M	0.03%	654
2015 Q4	$264M	Buy	256,244 +21,778	+9%	+$21.9M	0.04%	534
2015 Q3	$221M	Buy	234,466 +4,667	+2%	+$4.87M	0.03%	588
2015 Q2	$240M	Buy	+229,799	New	+$241M	0.03%	607

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Fidelity Investments's AGN.PRA Position: Q1 2018 in Review

Fidelity Investments sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 197,124 shares — an estimated $115M sold.

Fidelity Investments first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $269M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Fidelity Investments reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Fidelity Investments sold 197,124 Allergan plc shares in Q1 2018, an estimated $115M.
Fidelity Investments first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Fidelity Investments's Allergan plc position peaked at $269M in Q2 2016.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Fidelity Investments's 13F filing for Q1 2018, filed 14 May 2018.